Cowen & Co. analyst Doug Schenkel reiterated a Hold rating on PerkinElmer (NYSE: PKI) today and set a price target of $94. The company’s shares opened today at $97.60, close to its 52-week high of $98.33.
According to TipRanks.com, Schenkel is a top 100 analyst with an average return of 27.3% and a 73.9% success rate. Schenkel covers the Healthcare sector, focusing on stocks such as Becton Dickinson, Myriad Genetics, and NanoString Tech.
PerkinElmer has an analyst consensus of Hold, with a price target consensus of $88.80.
See today’s analyst top recommended stocks >>
Based on PerkinElmer’s latest earnings release for the quarter ending June 30, the company reported a quarterly net profit of $64.61 million. In comparison, last year the company had a net profit of $96.68 million.
Based on the recent corporate insider activity of 51 insiders, corporate insider sentiment is negative on the stock. Most recently, in August 2018, Patrick Sullivan, a Director at PKI sold 12,672 shares for a total of $1,092,200.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
PerkinElmer, Inc. (United States) engages in the provision of products, services, and solutions to diagnostics, food, environmental, industrial, life sciences research, and laboratory services markets. It operates through the Discovery and Analytical Solutions, and Diagnostics segments.
